Metformin, a widely used diabetes medication, shows promising benefits through the mTOR pathway, potentially enhancing survival rates in treated patients. Current research is exploring more specific drugs targeting this pathway, with ongoing human trials assessing their effectiveness and safety. The quest for universal applicability continues, raising questions about risks and side effects.
